Caroline Baumal

Insider Reports History

Location
Waltham, MA
Signature
/s/ David Watson, attorney-in-fact for Caroline Baumal
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Caroline Baumal:

Company Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Chief Medical Officer Common Stock 89,324 $1,767,980 $19.79 20 Jan 2026 Direct
Apellis Pharmaceuticals, Inc. Chief Medical Officer Stock Option (Right to Buy) 82,500 $1,599,675 $19.39 09 Jun 2025 Direct

Insider Reports Filed by Caroline Baumal

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APLS Apellis Pharmaceuticals, Inc. 20 Jan 2026 1 -$37,250 4 Chief Medical Officer 21 Jan 2026, 16:19
APLS Apellis Pharmaceuticals, Inc. 05 Jan 2026 1 -$77,097 4 Chief Medical Officer 06 Jan 2026, 16:06
APLS Apellis Pharmaceuticals, Inc. 09 Jun 2025 1 +$1,599,675 4 Chief Medical Officer 11 Jun 2025, 16:16
APLS Apellis Pharmaceuticals, Inc. 17 Jan 2025 2 -$55,513 4 Chief Medical Officer 21 Jan 2025, 15:54
APLS Apellis Pharmaceuticals, Inc. 06 Jan 2025 1 -$95,215 4 Chief Medical Officer 08 Jan 2025, 16:03
APLS Apellis Pharmaceuticals, Inc. 16 Jan 2024 2 +$2,453,100 4 Chief Medical Officer 17 Jan 2024, 16:33
APLS Apellis Pharmaceuticals, Inc. 04 Jan 2024 1 -$165,207 4 Chief Medical Officer 05 Jan 2024, 16:14
APLS Apellis Pharmaceuticals, Inc. 03 Jan 2023 0 $0 3 Chief Medical Officer 09 Jan 2023, 15:44
APLS Apellis Pharmaceuticals, Inc. 03 Jan 2023 2 +$2,463,720 4 Chief Medical Officer 05 Jan 2023, 18:57
APLS Apellis Pharmaceuticals, Inc. 03 Jan 2023 0 $0 3 Chief Medical Officer 05 Jan 2023, 18:48